Results According to the search results and defined exclusion criteria, a total of 51 studies were found suitable for analysis (Supplementary information S1)
Dienel SJ, Schoonover KE, Lewis DA
Key validation metrics include pharmacokinetics/pharmacodynamics concordance (e.g., clearance rates, area under the curve [AUC], metabolite formation), toxicological sensitivity and specificity, and the recapitulation of clinical-grade disease phenotypes and drug responses
The firm pointed to the extensive gross-to-net adjustments that the manufacturers are already providing on these drugs. BMO Capital Markets, for its part, wrote in a note to investors, We reiterate that the important comparison remains the difference between the products newly discounted price and the products ultimate net price, including rebates, instead of their list prices
*Antioxidants alone will not be effective in the majority of melasma cases